Literature DB >> 6229539

Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits.

A D Wegener, L R Jones.   

Abstract

Phosphorylation of purified phospholamban isolated from canine cardiac sarcoplasmic reticulum vesicles decreased the electrophoretic mobility of the protein in sodium dodecyl sulfate (SDS)-polyacrylamide gels. Different mobility forms of phospholamban in SDS gels were visualized both by direct protein staining and by autoradiography. Unphosphorylated phospholamban migrated with an apparent Mr = 25,000 in SDS gels; maximal phosphorylation of phospholamban by cAMP- or Ca2+-calmodulin-dependent protein kinase increased the apparent Mr to 27,000. Partial phosphorylation of phospholamban by either protein kinase gave intermediate mobility forms of molecular weights between 25,000 and 27,000, suggesting that more than one phosphorylation site was present on the holoprotein for each activity. Boiling of phospholamban in SDS dissociated the holoprotein into an apparently homogeneous class of low molecular weight "monomers." Only two mobility forms of monomeric phospholamban were observed in SDS gels after phosphorylation by cAMP-dependent protein kinase, corresponding to 9-kDa dephospho- and 11-kDa phosphoproteins. All of the 9-kDa protein could be phosphorylated and converted into the 11-kDa mobility form, suggesting the presence of only one site of phosphorylation on a single type of monomer for cAMP-dependent protein kinase. Simultaneous phosphorylation of monomeric phospholamban by cAMP-dependent protein kinase and Ca2+-calmodulin-dependent protein kinase gave an additional mobility form of the protein, suggesting that different sites of phosphorylation were present for each activity on each monomer. Incomplete dissociation of the holoprotein by boiling it in a relatively low concentration of SDS facilitated the detection of five major mobility forms of the protein in SDS gels, and the mobilities of all of these forms were decreased by phosphorylation. We propose that the high molecular weight form of phospholamban is a multimer of electrophoretically indistinguishable monomers, each of which contains a different phosphorylation site for cAMP-dependent protein kinase activity and Ca2+-calmodulin-dependent protein kinase activity. Phosphorylation of phospholamban at multiple sites is responsible for the various mobility forms of the holoprotein detected in SDS-polyacrylamide gels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.

Authors:  Brandy L Akin; Larry R Jones
Journal:  J Biol Chem       Date:  2012-01-14       Impact factor: 5.157

3.  Phospholamban phosphorylation increases the passive calcium leak from cardiac sarcoplasmic reticulum.

Authors:  Roozbeh Aschar-Sobbi; Teresa L Emmett; Gary J Kargacin; Margaret E Kargacin
Journal:  Pflugers Arch       Date:  2012-07-07       Impact factor: 3.657

4.  Protein Mobility Shifts Contribute to Gel Electrophoresis Liquid Chromatography Analysis.

Authors:  Nicholas J Carruthers; Graham C Parker; Theresa Gratsch; Joseph A Caruso; Paul M Stemmer
Journal:  J Biomol Tech       Date:  2015-09

5.  The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.

Authors:  Brandy L Akin; Thomas D Hurley; Zhenhui Chen; Larry R Jones
Journal:  J Biol Chem       Date:  2013-08-31       Impact factor: 5.157

6.  Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Authors:  Andrew S Murray; Fausto A Varela; Thomas E Hyland; Andrew J Schoenbeck; Jordan M White; Lauren M Tanabe; Sokol V Todi; Karin List
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

7.  Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex.

Authors:  Zhanjia Hou; Eileen M Kelly; Seth L Robia
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

8.  Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport.

Authors:  Vitaly V Vostrikov; Kaustubh R Mote; Raffaello Verardi; Gianluigi Veglia
Journal:  Structure       Date:  2013-10-24       Impact factor: 5.006

9.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

10.  Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.

Authors:  Arianna Rath; Mira Glibowicka; Vincent G Nadeau; Gong Chen; Charles M Deber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.